Methylphenidate Adverse Events Will Be Topic Of Pediatric Advisory Committee In June

As required by the Best Pharmaceuticals for Children Act, the advisory committee will review adverse event reports for Johnson & Johnson's Concerta and other methylphenidate products on June 30. Reports for other drugs will be considered June 29.